Hekma Saad Farghaly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hekma Saad Farghaly has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Kotb Abbass Metwalley
Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt
2 shared publications - Ahlam Badawy
Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publication - Ahmed M. Ali
Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publication - Amira M. Shalaby
Children Hospital, Faculty of Medicine, Hematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publication - Ashraf Elsaghier
Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publication - Ashraf Mohamed El-Saghier
Pediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publication
Latest Publications
- Open Access
- 20 October 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Assessment of hepcidin and iron status in children with untreated newly diagnosed graves’ hyperthyroidism
Graves’ disease (GD) is an autoimmune disease causing the overproduction of thyroid hormones from the thyroid gland. Hepcidin is an acute-phase prote
- 20 October 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessAssessment of hepcidin and iron status in children with untreated newly diagnosed graves’ hyperthyroidism
Graves’ disease (GD) is an autoimmune disease causing the overproduction of thyroid hormones from the thyroid gland. Hepcidin is an acute-phase prote
- Open Access
- 21 April 2026
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 74 (1) , 40
Biomarkers of cardiac injury in infants of diabetic mothers and its relation to echocardiographic findings
Background: Infants of diabetic mothers (IDMs) are predisposed to transient hypertrophic cardiomyopathy and subclinical myocardial dysfunction. However, validated diagnostic cut-off values for cardiac biomarkers in this population are lacking, and the relationship between a panel of multiple biomarkers and advanced echocardiographic indices has not been systematically established. This study aimed to evaluate cardiac troponin-I (cTnI), B-type natriuretic peptide (BNP), and creatine kinase-MB (CK-MB) in IDMs, correlate them with conventional and advanced echocardiographic parameters, and derive ROC-based diagnostic cut-off values for detecting echocardiographically defined cardiac dysfunction. Methods: In this prospective cross-sectional study, 100 term IDMs and 50 healthy controls were enrolled. Maternal glycemic control was assessed using HbA1c. Neonatal serum cTnI, BNP, and CK-MB were measured within 24–48 h of birth. Comprehensive echocardiography included M-mode measurements, left ventricular mass (Devereux formula), fractional shortening, myocardial performance index (pulsed-wave tissue Doppler at the lateral mitral annulus), E/A ratio, and E/E′ ratio. ROC analysis determined optimal diagnostic cut-offs. Results: IDMs had significantly higher cTnI (0.42 ± 0.18 vs. 0.09 ± 0.03 ng/mL), BNP (165 ± 60 vs. 60 ± 20 pg/mL), and CK-MB (85 ± 25 vs. 45 ± 18 U/L) compared to controls (all p < 0.001). Echocardiography revealed increased interventricular septal thickness and left ventricular mass ( p < 0.001), preserved fractional shortening, but elevated MPI and E/E′ ratio indicating diastolic dysfunction (both p < 0.001). IDMs also had higher rates of transient tachypnea (18% vs. 4%, p = 0.02), feeding difficulties (15% vs. 2%, p = 0.01), and longer hospital stay (5.2 ± 2.1 vs. 3.1 ± 1.0 days, p < 0.001). Maternal HbA1c correlated strongly with cTnI ( r = 0.62) and BNP ( r = 0.54). ROC analysis identified cTnI as the most accurate biomarker (AUC = 0.89; cut-off > 0.12 ng/mL; sensitivity 88%, specificity 84%). Conclusions: Elevated cTnI, BNP, and CK-MB in IDMs reflect cardiac stress linked to maternal hyperglycemia. Population-specific biomarker cut-offs, particularly cTnI > 0.12 ng/mL, may facilitate non-invasive screening for subclinical cardiac dysfunction, guiding selective echocardiography use. These thresholds require prospective multicenter validation.
- 21 April 2026
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 74 (1) , 40
Open AccessBiomarkers of cardiac injury in infants of diabetic mothers and its relation to echocardiographic findings
Background: Infants of diabetic mothers (IDMs) are predisposed to transient hypertrophic cardiomyopathy and subclinical myocardial dysfunction. However, validated diagnostic cut-off values for cardiac biomarkers in this population are lacking, and the relationship between a panel of multiple biomarkers and advanced echocardiographic indices has not been systematically established. This study aimed to evaluate cardiac troponin-I (cTnI), B-type natriuretic peptide (BNP), and creatine kinase-MB (CK-MB) in IDMs, correlate them with conventional and advanced echocardiographic parameters, and derive ROC-based diagnostic cut-off values for detecting echocardiographically defined cardiac dysfunction. Methods: In this prospective cross-sectional study, 100 term IDMs and 50 healthy controls were enrolled. Maternal glycemic control was assessed using HbA1c. Neonatal serum cTnI, BNP, and CK-MB were measured within 24–48 h of birth. Comprehensive echocardiography included M-mode measurements, left ventricular mass (Devereux formula), fractional shortening, myocardial performance index (pulsed-wave tissue Doppler at the lateral mitral annulus), E/A ratio, and E/E′ ratio. ROC analysis determined optimal diagnostic cut-offs. Results: IDMs had significantly higher cTnI (0.42 ± 0.18 vs. 0.09 ± 0.03 ng/mL), BNP (165 ± 60 vs. 60 ± 20 pg/mL), and CK-MB (85 ± 25 vs. 45 ± 18 U/L) compared to controls (all p < 0.001). Echocardiography revealed increased interventricular septal thickness and left ventricular mass ( p < 0.001), preserved fractional shortening, but elevated MPI and E/E′ ratio indicating diastolic dysfunction (both p < 0.001). IDMs also had higher rates of transient tachypnea (18% vs. 4%, p = 0.02), feeding difficulties (15% vs. 2%, p = 0.01), and longer hospital stay (5.2 ± 2.1 vs. 3.1 ± 1.0 days, p < 0.001). Maternal HbA1c correlated strongly with cTnI ( r = 0.62) and BNP ( r = 0.54). ROC analysis identified cTnI as the most accurate biomarker (AUC = 0.89; cut-off > 0.12 ng/mL; sensitivity 88%, specificity 84%). Conclusions: Elevated cTnI, BNP, and CK-MB in IDMs reflect cardiac stress linked to maternal hyperglycemia. Population-specific biomarker cut-offs, particularly cTnI > 0.12 ng/mL, may facilitate non-invasive screening for subclinical cardiac dysfunction, guiding selective echocardiography use. These thresholds require prospective multicenter validation.
- Open Access
- 6 April 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (6) , 2793-2800
Endothelial dysfunction in children with newly diagnosed Graves’ disease
The most frequent cause of hyperthyroidism in children is Graves’ disease (GD). Vascular endothelium is a specific target of thyroid hormone. The purpose of this study is to assess flow-mediated dilatation (FMD)% and serum von Willebrand factor (vWF) levels in children with newly diagnosed GD to reflect the extent of endothelial dysfunction in those children. In this study, 40 children with newly discovered GD and 40 children who were healthy served as the control group. Both patients and controls had anthropometric assessment, as well as measurements of fasting lipids, glucose, insulin, high-sensitivity C-reactive protein (hs-CRP), TSH, and free thyroxine (FT4 and FT3), thyrotropin receptor antibodies TRAbs and vWF. Noninvasive ultrasound was utilized to quantify the carotid arteries’ intima-media thickness and the brachial artery’s FMD. Patients reported significantly reduced FMD response and greater vWF and hs-CRP levels compared to controls (P = 0.001 for each). In multivariate analysis, we reported that vWF was significantly correlated with TSH (OR 2.5, 95% CI 1.32–5.32, P = 0.001), FT3 (OR 3.4, 95% CI 1.45–3.55, P = 0.001), TRAb (OR 2.1, 95% CI 1.16–2.23, P = 0.01), and FMD% (OR 4.2, 95% CI 1.18–8.23, P = 0.001). Conclusions: Children with newly diagnosed GD have endothelial dysfunction, which is shown by impaired FMD and increased vWF. These findings support the idea that GD may need to be treated as soon as possible. What is Known:• Graves' disease is the most common cause of hyperthyroidism in children.• vWF is a reliable marker for detection of vascular endothelial dysfunction. What is New:• Children with newly diagnosed Graves' disease may have endothelial dysfunction as reflected by impairment of FMD and raised vWF level.• Measurement of vWF level in children with newly diagnosed Graves' disease can be used for early detection of endothelial dysfunction.
- 6 April 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (6) , 2793-2800
Open AccessEndothelial dysfunction in children with newly diagnosed Graves’ disease
The most frequent cause of hyperthyroidism in children is Graves’ disease (GD). Vascular endothelium is a specific target of thyroid hormone. The purpose of this study is to assess flow-mediated dilatation (FMD)% and serum von Willebrand factor (vWF) levels in children with newly diagnosed GD to reflect the extent of endothelial dysfunction in those children. In this study, 40 children with newly discovered GD and 40 children who were healthy served as the control group. Both patients and controls had anthropometric assessment, as well as measurements of fasting lipids, glucose, insulin, high-sensitivity C-reactive protein (hs-CRP), TSH, and free thyroxine (FT4 and FT3), thyrotropin receptor antibodies TRAbs and vWF. Noninvasive ultrasound was utilized to quantify the carotid arteries’ intima-media thickness and the brachial artery’s FMD. Patients reported significantly reduced FMD response and greater vWF and hs-CRP levels compared to controls (P = 0.001 for each). In multivariate analysis, we reported that vWF was significantly correlated with TSH (OR 2.5, 95% CI 1.32–5.32, P = 0.001), FT3 (OR 3.4, 95% CI 1.45–3.55, P = 0.001), TRAb (OR 2.1, 95% CI 1.16–2.23, P = 0.01), and FMD% (OR 4.2, 95% CI 1.18–8.23, P = 0.001). Conclusions: Children with newly diagnosed GD have endothelial dysfunction, which is shown by impaired FMD and increased vWF. These findings support the idea that GD may need to be treated as soon as possible. What is Known:• Graves' disease is the most common cause of hyperthyroidism in children.• vWF is a reliable marker for detection of vascular endothelial dysfunction. What is New:• Children with newly diagnosed Graves' disease may have endothelial dysfunction as reflected by impairment of FMD and raised vWF level.• Measurement of vWF level in children with newly diagnosed Graves' disease can be used for early detection of endothelial dysfunction.